Investing.com - Wave Life Sciences (NASDAQ:WVE) Ltd reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Wave Life Sciences Ltd announced earnings per share of $-0.420 on revenue of $290K. Analysts polled by Investing.com anticipated EPS of $-0.480 on revenue of $8.73M.
Wave Life Sciences Ltd shares are down 24% from the beginning of the year, still down 25.80% from its 52 week high of $5.31 set on October 17.
Wave Life Sciences Ltd shares gained 0.25% in pre-market trade following the report.
Wave Life Sciences Ltd follows other major Healthcare sector earnings this month
Wave Life Sciences Ltd's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar